Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sara Santagata
Observed names:
S Santagata,
S. Santagata,
Santagata, Sara
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
Federico II University Hospital,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
University of Naples Federico II
ORCID:
0000-0001-8680-084X
Observed ORCID:
0000-0001-8680-084X
OpenAlex ID:
A5074752379
IL-15 Interferes With Suppressive Activity of Intestinal Regulatory T Cells Expanded in Celiac Disease
2011
·
Delia Zanzi
, Rosita Stefanile
, et al.
·
The American Journal of Gastroenterology
·
119
CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment
2021
·
Sara Santagata
, Caterina Ieranò
, et al.
·
Frontiers in Oncology
·
117
PDF
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells
2014
·
C Ieranò
, S Santagata
, et al.
·
Cell Death and Disease
·
88
PDF
Gliadin-Mediated Proliferation and Innate Immune Activation in Celiac Disease Are Due to Alterations in Vesicular Trafficking
2011
·
M. Vittoria Barone
, Delia Zanzi
, et al.
·
PLoS ONE
·
86
PDF
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer
2017
·
Sara Santagata
, Maria Napolitano
, et al.
·
Oncotarget
·
85
PDF
In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies
2022
·
Caterina Ieranò
, Dario Righelli
, et al.
·
Journal for ImmunoTherapy of Cancer
·
74
PDF
Gliadin Peptide P31-43 Localises to Endocytic Vesicles and Interferes with Their Maturation
2010
·
Maria Vittoria Barone
, Merlin Nanayakkara
, et al.
·
PLoS ONE
·
74
PDF
Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach
2017
·
Davide Gentilini
, Stefania Scala
, et al.
·
Oncotarget
·
72
PDF
CXCR4–CXCL12–CXCR7, TLR2–TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients
2016
·
Crescenzo D'Alterio
, Guglielmo Nasti
, et al.
·
OncoImmunology
·
51
PDF
Immunoregulatory Pathways Are Active in the Small Intestinal Mucosa of Patients with Potential Celiac Disease
2013
·
Melissa Borrelli
, Virginia M Salvati
, et al.
·
The American Journal of Gastroenterology
·
45
Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment
2023
·
Sara Santagata
, Giuseppina Rea
, et al.
·
Hepatology International
·
30
PDF
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
2020
·
Crescenzo D’Alterio
, Antonella Zannetti
, et al.
·
Cancers
·
28
PDF
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
2018
·
Anna Maria Trotta
, Sara Santagata
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
24
PDF
Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors
2021
·
Anna Maria Trotta
, Michela Aurilio
, et al.
·
Journal of Medicinal Chemistry
·
23
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors
2017
·
Sara Santagata
, Luigi Portella
, et al.
·
Scientific Reports
·
22
PDF
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients
2024
·
Sara Santagata
, Giuseppina Rea
, et al.
·
British Journal of Cancer
·
17
PDF
Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study
2021
·
Alessandro Ottaiano
, Angela Petito
, et al.
·
Cancers
·
10
PDF
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization
2024
·
Luigi Portella
, Giulia Bertolini
, et al.
·
Heliyon
·
9
KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer
2024
·
Sara Santagata
, Anna Maria Trotta
, et al.
·
Clinical Cancer Research
·
7
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification
2024
·
Anna Maria Trotta
, Vincenzo Mazzarella
, et al.
·
European Journal of Medicinal Chemistry
·
3
Basal NK activity and early Treg function inhibition predicts Nivolumab responsiveness in metastatic renal cancer patients (REVOLUTION) trial
2019
·
S. Santagata
, A.M. Trotta
, et al.
·
Annals of Oncology
·
3
Abstract 6675: Basal NK activity and early Tregs inhibition predicts nivolumab responsiveness in metastatic renal cancer patients (REVOLUTION) trial
2020
·
Sara Santagata
, Anna Maria Trotta
, et al.
·
Cancer Research
·
2
CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cells
2026
·
Federica Auletta
, Caterina Ieranò
, et al.
·
Cell Death Discovery
·
1
PDF
Abstract 6815: CXCL12-loaded-hydrogel (CLG) in vivo modifies lung metastatic niche toward an immunoactive microenvironment reducing lung metastasis development
2024
·
Giuseppe Guardascione
, Luigi Portella
, et al.
·
Cancer Research
·
1
Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study
2023
·
Alessandro Ottaiano
, Antonella De Luca
, et al.
·
BMC Cancer
·
1
PDF
Show more works
View as search
Works count:
68
Citation count:
995
H-index:
16
I10-index:
17
Year
Topic
Type